Back
Astrana Health Vs. Aligos Therapeutics Industry Stock Comparison
Sell
36
ASTH
Astrana Health
Last Price:
$32.5500
Seasonality Move:
2.53%
Buy
65
ALGS
Aligos Therapeutics
Last Price:
$41.87
Seasonality Move:
-16.03%
Sell
36
Astrana Health (ASTH)
is a Sell
Is Astrana Health a Buy, Sell or Hold?
-
The current Astrana Health [ASTH] share price is $33.5300. The Score for ASTH is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
ASTH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
65
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
-
The current Aligos Therapeutics [ALGS] share price is $43.37. The Score for ALGS is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ASTH Stock Price Chart
What is Astrana Health's stock price today?
-
The Astrana Health share price today is $33.5300Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASTH is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $43.37Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
ASTH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.41 | Sell |
Relative Strength Index (14 RSI): | 18.91 | Sell |
Chaikin Money Flow: | 207941 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (35.5782 - 42.9782) | Sell |
Bollinger Bands (100): | (41.3051 - 56.9251) | Sell |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.71 | Buy |
Relative Strength Index (14 RSI): | 81.52 | Buy |
Chaikin Money Flow: | 630913 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (22.74 - 36.8) | Buy |
Bollinger Bands (100): | (6.83 - 25.23) | Buy |
ASTH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 34.58 | Sell |
20-day SMA: | 38.59 | Sell |
50-day SMA: | 45.96 | Sell |
200-day SMA: | 45.36 | Sell |
8-day EMA: | 34.79 | Sell |
20-day EMA: | 37.88 | Sell |
50-day EMA: | 43.26 | Sell |
200-day EMA: | 45.03 | Sell |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 37.61 | Buy |
20-day SMA: | 32.22 | Buy |
50-day SMA: | 20.6 | Buy |
200-day SMA: | 16.51 | Buy |
8-day EMA: | 38.12 | Buy |
20-day EMA: | 32.66 | Buy |
50-day EMA: | 24.43 | Buy |
200-day EMA: | 18.11 | Buy |
Astrana Health Earnings Growth & ASTH Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.44 per share, and an increase next year of $0.14 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
Astrana Health Technical Analysis
Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |